1Devaux, M & Sassi, F (2011) Social inequalities in obesity and overweight in 11 OECD countries. Eur J Public Health .
3Prentice, AM & Jebb, SA (2001) Beyond body mass index. Obes Rev 2, 141–147.
4Deurenberg, P & Deurenberg-Yap, M (2003) Validity of body composition methods across ethnic population groups. Forum Nutr 56, 299–301.
5Kragelund, C & Omland, T (2005) A farewell to body-mass index? Lancet 366, 1589–1591.
6Okorodudu, DO, Jumean, MF, Montori, VM, et al. . (2010) Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes 34, 791–799.
7Thomas, EL, Parkinson, JR, Frost, GS, et al. . (2012) The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity 20, 76–87.
8Zhao, J, Bradfield, JP, Zhang, H, et al. . (2011) Role of BMI-associated loci identified in GWAS meta-analyses in the context of common childhood obesity in European Americans. Obesity 19, 2436–2439.
9Walters, RG, Jacquemont, S, Valsesia, A, et al. . (2010) A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 463, 671–675.
10Klein, S, Allison, DB, Heymsfield, SB, et al. . (2007) Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30, 1647–1652.
11Pouliot, MC, Després, JP, Lemieux, S, et al. . (1994) Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73, 460–468.
12Lean, ME, Han, TS & Morrison, CE (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311, 158–161.
13Janssen, I, Katzmarzyk, PT & Ross, R (2002) Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 162, 2074–2079.
14Wang, Y, Rimm, EB, Stampfer, MJ, et al. . (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81, 555–563.
15Deurenberg, P (1996) Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity. Am J Clin Nutr 64, Suppl. 3, S449–S452.
16Bonora, E, Micciolo, R, Ghiatas, AA, et al. . (1995) Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism 44, 1617–1625.
17Tothill, P, Han, TS, Avenell, A, et al. . (1996) Comparisons between fat measurements by dual-energy X-ray absorptiometry, underwater weighing and magnetic resonance imaging in healthy women. Eur J Clin Nutr 50, 747–752.
18Thomas, EL, Saeed, N, Hajnal, JV, et al. . (1998) Magnetic resonance imaging of total body fat. J Appl Physiol 85, 1778–1785.
19Pou, KM, Massaro, JM, Hoffmann, U, et al. . (2009) Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 32, 481–485.
20Mehta, SR, Thomas, EL, Patel, N, et al. . (2010) Proton magnetic resonance spectroscopy and ultrasound for hepatic fat quantification. Hepatol Res 40, 399–406.
21Thomas, EL, Collins, AL, McCarthy, J, et al. . (2010) Estimation of abdominal fat compartments by bioelectrical impedance: the validity of the ViScan measurement system in comparison with MRI. Eur J Clin Nutr 64, 525–533.
22Fowler, PA, Fuller, MF, Glasbey, CA, et al. . (1991) Total and subcutaneous adipose tissue in women: the measurement of distribution and accurate prediction of quantity by using magnetic resonance imaging. Am J Clin Nutr 54, 18–25.
23Ross, R, Léger, L, Morris, D, et al. . (1992) Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72, 787–795.
24Barnard, ML, Schwieso, JE, Thomas, EL, et al. . (1996) Development of a rapid and efficient magnetic resonance imaging technique for analysis of body fat distribution. NMR Biomed 9, 156–164.
25Mitsiopoulos, N, Baumgartner, RN, Heymsfield, SB, et al. . (1998) Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85, 115–122.
26Thomas, EL & Bell, JD (2003) Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 27, 211–218.
27Machann, J, Thamer, C, Schnoedt, B, et al. . (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21, 455–462.
28Sohlström, A, Wahlund, LO & Forsum, E (1993) Adipose tissue distribution as assessed by magnetic resonance imaging and total body fat by magnetic resonance imaging, underwater weighing, and body-water dilution in healthy women. Am J Clin Nutr 58, 830–838.
29Harrington, TA, Thomas, EL, Modi, N, et al. . (2002) Fast and reproducible method for the direct quantitation of adipose tissue in newborn infants. Lipids 37, 95–100.
30Olhager, E, Flinke, E, Hannerstad, U, et al. . (2003) Studies on human body composition during the first 4 months of life using magnetic resonance imaging and isotope dilution. Pediatr Res 54, 906–912.
31O'Regan, DP, Callaghan, MF, Wylezinska-Arridge, M, et al. . (2008) Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T – feasibility. Radiology 247, 550–557.
32Springer, F, Machann, J, Schwenzer, NF, et al. . (2010) Quantitative assessment of intrahepatic lipids using fat-selective imaging with spectral-spatial excitation and in-/opposed-phase gradient echo imaging techniques within a study population of extremely obese patients: feasibility on a short, wide-bore MR scanner. Invest Radiol 45, 484–490.
33Schwenzer, NF, Machann, J, Martirosian, P, et al. . (2008) Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 43, 330–337.
34Borra, RJ, Salo, S, Dean, K, et al. . (2009) Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 250, 130–136.
35Hu, HH, Kim, HW, Nayak, KS, et al. . (2010) Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity 18, 841–847.
36Yokoo, T, Shiehmorteza, M, Hamilton, G, et al. . (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258, 749–759.
37Yokoo, T, Bydder, M, Hamilton, G, et al. . (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 25, 67–76.
38Meisamy, S, Hines, CD, Hamilton, G, et al. . (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modelling of fat: blinded comparison with MR spectroscopy. Radiology 258, 767–775.
39Hu, HH, Nayak, KS & Goran, MI (2011) Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging. Obes Rev 12, e504–e515.
40Schick, F, Eismann, B, Jung, WI, et al. . (1993) Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29, 158–167.
41Boesch, C, Slotboom, J, Hoppeler, H, et al. . (1997) In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37, 484–493.
42Rico-Sanz, J, Thomas, EL, Jenkinson, G, et al. . (1999) Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS. J Appl Physiol 87, 2068–2072.
43Szczepaniak, LS, Babcock, EE, Schick, F, et al. . (1999) Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo. Am J Physiol 276, E977–E989.
44Howald, H, Boesch, C, Kreis, R, et al. . (2002) Content of intramyocellular lipids derived by electron microscopy, biochemical assays, and (1)H-MR spectroscopy. J Appl Physiol 92, 2264–2272.
45Thomas, EL, Hamilton, G, Patel, N, et al. . (2005) Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54, 122–127.
46Szczepaniak, LS, Nurenberg, P, Leonard, D, et al. . (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288, E462–E468.
47Hamilton, G, Yokoo, T, Bydder, M, et al. . (2010) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24, 784–790.
48Machann, J, Thamer, C, Schnoedt, B, et al. . (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55, 913–917.
49Tarasów, E, Siergiejczyk, L, Panasiuk, A, et al. . (2002) MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 8, MT36–MT40.
50Thomas, EL & Bell, JD (2006) Intra-cellular fat accumulation, mechanisms and implications for health. Int J Body Comp Res 4, 39–43.
51Lingvay, I, Esser, V, Legendre, JL, et al. . (2009) Non-invasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94, 4070–4076.
52Szczepaniak, LS, Dobbins, RL & Metzger, GJ (2003) Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49, 417–423.
53Demerath, EW, Reed, D, Rogers, N, et al. . (2008) Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 88, 1263–1271.
54Fabbrini, E, Magkos, F, Mohammed, BS, et al. . (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106, 15430–15435.
55Hwang, JH, Stein, DT, Barzilai, N, et al. . (2007) Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 293, E1663–E1669.
56Porter, SA, Massaro, JM, Hoffmann, U, et al. . (2009) Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32, 1068–1075.
57Montague, CT, Prins, JB, Sanders, L, et al. . (1997) Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46, 342–347.
58Goldstone, AP, Brynes, AE, Thomas, EL, et al. . (2002) Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr 75, 468–475.
59Magni, P, Liuzzi, A, Ruscica, M, et al. . (2005) Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol 62, 189–196.
60Forouhi, NG, Jenkinson, G, Thomas, EL, et al. . (1999) Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42, 932–935.
61Sinha, R, Dufour, S, Petersen, KF, et al. . (2002) Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51, 1022–1027.
62Gan, SK, Kriketos, AD, Poynten, AM, et al. . (2003) Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res 11, 1295–1305.
63Thomas, EL, Frost, G, Barnard, ML, et al. . (1996) An in vivo 13C magnetic resonance spectroscopic study of the relationship between diet and adipose tissue composition. Lipids 31, 145–151.
64Hwang, JH, Bluml, S, Leaf, A, et al. . (2003) In vivo characterization of fatty acids in human adipose tissue using natural abundance 1H decoupled 13C MRS at 1.5 T: clinical applications to dietary therapy. NMR Biomed 16, 160–167.
65Jones, A Jr, Shen, W, St-Onge, MP, et al. . (2004) Body-composition differences between African American and white women: relation to resting energy requirements. Am J Clin Nutr 79, 780–786.
66Liska, D, Dufour, S, Zern, TL, et al. . (2007) Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS One 2, e569.
67Lê, KA, Ventura, EE, Fisher, JQ, et al. . (2011) Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care 34, 485–490.
68Harrington, TA, Thomas, EL, Frost, G, et al. . (2004) Distribution of adipose tissue in the newborn. Pediatr Res 55, 437–441.
69Modi, N, Thomas, EL, Harrington, TA, et al. . (2006) Determinants of adiposity during preweaning postnatal growth in appropriately grown and growth-restricted term infants. Pediatr Res 60, 345–348.
70Kuk, JL & Ross, R (2009) Influence of sex on total and regional fat loss in overweight and obese men and women. Int J Obes 33, 629–634.
71Rankinen, T, Zuberi, A, Chagnon, YC, et al. . (2006) The human obesity gene map: the 2005 update. Obesity 14, 529–644.
72Kilpeläinen, TO, Zillikens, MC, Stančákova, A, et al. . (2011) Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 43, 753–760.
73Speliotes, EK, Willer, CJ, Berndt, SI, et al. . (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42, 937–948.
74Lindgren, CM, Heid, IM, Randall, JC, et al. . (2009) Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet 5, e1000508.
75Heid, IM, Jackson, AU, Randall, JC, et al. . (2010) Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 42, 949–960.
76Speliotes, EK, Massaro, JM, Hoffmann, U, et al. . (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 51, 1979–1987.
77Must, A, Spadano, J, Coakley, EH, et al. . (1999) The disease burden associated with overweight and obesity. JAMA 282, 1523–1529.
78Després, JP, Lemieux, I, Bergeron, J, et al. . (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28, 1039–1049.
79Kuk, JL, Katzmarzyk, PT, Nichaman, MZ, et al. . (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity 14, 336–341.
80Stefan, N, Kantartzis, K, Machann, J, et al. . (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168, 1609–1616.
81Wildman, RP, Muntner, P, Reynolds, K, et al. . (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168, 1617–1624.
82McAuley, PA & Blair, SN (2011) Obesity paradoxes. J Sports Sci 29, 773–782.
83Pataky, Z, Makoundou, V & Nilsson, P (2011) Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int J Obes 35, 1208–1215.
84Karelis, AD, St-Pierre, DH, Conus, F, et al. . (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89, 2569–2575.
85Ferrannini, E, Natali, A, Bell, P, et al. . (1997) Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100, 1166–1173.
86Bonora, E, Kiechl, S, Willeit, J, et al. . (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47, 1643–1649.
87Wildman, RP (2009) Healthy obesity. Curr Opin Clin Nutr Metab Care 12, 438–443.
88Lee, CD, Blair, SN & Jackson, AS (1999) Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 69, 373–380.
89Wei, M, Kampert, JB, Barlow, CE, et al. . (1999) Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 282, 1547–1553.
90O'Donovan, G, Thomas, EL, McCarthy, JP, et al. . (2009) Fat distribution in men of different waist girth, fitness level and exercise habit. Int J Obes 33, 1356–1362.
91Björntorp, P (1991) Metabolic implications of body fat distribution. Diabetes Care 14, 1132–1143.
92Brochu, M, Tchernof, A, Dionne, IJ, et al. . (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86, 1020–1025.
93Matsuzawa, Y (1997) Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 13, 3–13.
94Matsuzawa, Y, Fujioka, S, Tokunaga, K, et al. . (1992) Classification of obesity with respect to morbidity. Proc Soc Exp Biol Med 200, 197–201.
95Lee, DC, Sui, X & Blair, SN (2009) Does physical activity ameliorate the health hazards of obesity? Br J Sports Med 43, 49–51.
96Ruderman, NB, Schneider, SH & Berchtold, P (1981) The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 34, 1617–1621.
97Conus, F, Rabasa-Lhoret, R & Péronnet, F (2007) Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 32, 4–12.
98De Lorenzo, A, Martinoli, R, Vaia, F, et al. . (2006) Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 16, 513–523.
99Conus, F, Allison, DB, Rabasa-Lhoret, R, et al. . (2004) Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 89, 5013–5020.
100St-Onge, MP, Janssen, I & Heymsfield, SB (2004) Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 27, 2222–2228.
101Katsuki, A, Sumida, Y, Urakawa, H, et al. . (2003) Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26, 2341–2344.
102Dvorak, RV, DeNino, WF, Ades, PA, et al. . (1999) Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 48, 2210–2214.
103Ruderman, N, Chisholm, D, Pi-Sunyer, X, et al. . (1998) The metabolically obese, normal-weight individual revisited. Diabetes 47, 699–713.
104Matsuzawa, Y, Nakamura, T, Shimomura, I, et al. . (1995) Visceral fat accumulation and cardiovascular disease. Obes Res 3, Suppl. 5, 645S–647S.
105Després, JP & Lemieux, I (2006) Abdominal obesity and metabolic syndrome. Nature 444, 881–887.
106Unger, RH, Zhou, YT & Orci, L (1999) Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci U S A 96, 2327–2332.
107Unger, RH (1995) Lipotoxicity in the pathogenesis of obesity dependent NIDDM. Genetic and clinical implications. Diabetes 44, 863–870.
108Unger, RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144, 5159–5165.
109Montani, JP, Carroll, JF, Dwyer, TM, et al. . (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28, S58–S65.
110Petersen, KF, Oral, EA, Dufour, S, et al. . (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109, 1345–1350.
111Hegele, RA, Joy, TR, Al-Attar, SA, et al. . (2007) Thematic review series: Adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 48, 1433–1444.
112Stearns, SB, Tepperman, HM & Tepperman, J (1979) Studies on the utilization and mobilization of lipid in skeletal muscles from streptozotocin-diabetic and control rats. J Lipid Res 20, 654–662.
113Standl, E, Lotz, N, Dexel, T, et al. . (1980) Muscle triglycerides in diabetic subjects. Effect of insulin deficiency and exercise. Diabetologia 18, 463–469.
114Falholt, K, Jensen, I, Lindkaer, Jensen S, et al. . (1988) Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med 5, 27–31.
115Storlien, LH, Jenkins, AB, Chisholm, DJ, et al. . (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40, 280–289.
116Kraegen, EW, Clark, PW, Jenkins, AB, et al. . (1991) Development of muscle insulin resistance after liver insulin resistance in high fat-fed rats. Diabetes 40, 1397–1403.
117Phillips, DI, Caddy, S, Ilic, V, et al. . (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in non diabetic subjects. Metabolism 45, 947–950.
118Pan, DA, Lillioja, S, Kriketos, AD, et al. . (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983–988.
119Pepper, W (1884) Saccharine diabetes. Med Rec 25, 9–12.
120Zelman, S (1952) The liver in obesity. Arch Int Med 90, 141–156.
121Connor, CL (1938) Fatty infiltration of the liver and the development of cirrhosis in diabetes and chronic alcoholism. Am J Pathol 14, 347–364.
122Leevy, CM, Ryan, CM & Fineberg, JC (1950) Diabetes mellitus and liver dysfunction – etiological and therapeutic considerations. Am J Med 8, 290–299.
123Kern, WH, Heger, AH & Payne, JH (1973) Fatty metamorphosis of the liver in morbid obesity. Arch Pathol 96, 342–346.
124Ekstedt, M, Franzén, LE, Mathiesen, UL, et al. . (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865–873.
125Adams, LA, Waters, OR, Knuiman, MW, et al. . (2009) NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 104, 861–867.
126Powell, EE, Cooksley, WG, Hanson, R, et al. . (1990) The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 74–80.
127Vernon, G, Baranova, A & Younossi, ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34, 274–285.
128Bays, H, Mandarino, L & DeFronzo, RA (2004) Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89, 463–478.
129Lelliott, C & Vidal-Puig, AJ (2004) Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int J Obes Relat Metab Disord 28, Suppl. 4, S22–S28.
130Dasarathy, S, Dasarathy, J, Khiyami, A, et al. . (2009) Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51, 1061–1067.
131Magkos, F, Fabbrini, E, Mohammed, BS, et al. . (2010) Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity 18, 1510–1515.
132Yim, JE, Heshka, S, Albu, J, et al. . (2007) Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes 31, 1400–1405.
133Goodpaster, BH, Thaete, FL, Simoneau, JA, et al. . (1997) Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46, 1579–1585.
134Thomas, EL, Brynes, AE, McCarthy, J, et al. . (2000) Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids 35, 769–776.
135Idoate, F, Ibañez, J, Gorostiaga, EM, et al. . (2011) Weight-loss diet alone or combined with resistance training induces different regional visceral fat changes in obese women. Int J Obes 35, 700–713.
136van der Heijden, GJ, Wang, ZJ, Chu, ZD, et al. . (2010) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity 18, 384–390.
137Johnson, NA, Sachinwalla, T, Walton, DW, et al. . (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50, 1105–1112.
138Ross, R, Janssen, I, Dawson, J, et al. . (2004) Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 12, 789–798.
139Larson-Meyer, DE, Heilbronn, LK, Redman, LM, et al. . (2006) Effect of calorie restriction with or without exercise on insulin sensitivity, β-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 29, 1337–1344.
140Thomas, EL, Brynes, AE, Hamilton, G, et al. . (2006) Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 12, 5813–5819.
141Gasteyger, C, Larsen, TM, Vercruysse, F, et al. . (2009) Visceral fat loss induced by a low-calorie diet: a direct comparison between women and men. Diabetes Obes Metab 11, 596–602.
142Janssen, I, Fortier, A, Hudson, R, et al. . (2002) Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 25, 431–438.
143Doucet, E, St-Pierre, S, Alméras, N, et al. . (2002) Reduction of visceral adipose tissue during weight loss. Eur J Clin Nutr 56, 297–304.
144Leenen, R, van der Kooy, K, Droop, A, et al. . (1993) Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women. Arterioscler Thromb 13, 487–494.
145Montgomery, HE, Marshall, R, Hemingway, H, et al. . (1998) Human gene for physical performance. Nature 393, 221–222.
146Rankinen, T, Roth, SM, Bray, MS, et al. . (2010) Advances in exercise, fitness, and performance genomics. Med Sci Sports Exerc 42, 835–846.
147Bouchard, C (2008) Gene–environment interactions in the etiology of obesity: defining the fundamentals. Obesity 3, Suppl., S5–S10.
148Hannukainen, JC, Borra, R, Linderborg, K, et al. . (2011) Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol 54, 545–552.
149Mustelin, L, Pietiläinen, KH & Rissanen, A (2008) Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Am J Physiol Endocrinol Metab 295, E148–E154.